2026 Prices for Drugs That Are Subject to Negotiations

2026 Prices for Drugs That Are Subject to Negotiations

The New York Times - Business:

The prices were made possible by the Inflation Reduction Act, which granted the health secretary the authority to negotiate on behalf of Medicare.

This post first appeared in The New York Times - Business. Read the original article.